416 results on '"Gent, Dik C."'
Search Results
2. Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests
Catalog
Books, media, physical & digital resources
3. Development of an Ex Vivo Functional Assay for Prediction of Irradiation Related Toxicity in Healthy Oral Mucosa Tissue
4. Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient
5. Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
6. Role of the DNA damage response in prostate cancer formation, progression and treatment
7. The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells
8. Nonhomologous End-Joining
9. Supplementary Data from A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture
10. Data from A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture
11. Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response
12. Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma
13. XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination
14. Supplemental legend from Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects
15. Figure S3 from Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects
16. Table S1, Table S2, Table S3 from Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects
17. Data from A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair
18. Supplementary Data from A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair
19. Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response
20. Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma
21. DNA damage response and anti-apoptotic proteins predict radiosensitization efficacy of HDAC inhibitors SAHA and LBH589 in patient-derived glioblastoma cells
22. Correction to: Role of the DNA damage response in prostate cancer formation, progression and treatment
23. Spatiotemporal Aspects of MicroRNA-Mediated Gene Regulation
24. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes
25. tumors may acquire therapy resistance through expression of RING-less BRCA1
26. Rejoining of DNA by the RAG1 and RAG2 Proteins
27. Similarities between Initiation of V(D)J Recombination and Retroviral Integration
28. Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity
29. The COMPLETE trial:HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study
30. Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment
31. Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer
32. A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture
33. Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests
34. REV7 counteracts DNA double-strand break resection and affects PARP inhibition
35. Abstract 805: RECAP (REpair CAPacity) identifies a subset of breast cancers unable to form RAD51 foci which are undetected by DNA-based BRCAness tests
36. The COMPLETE trial: HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study
37. Initiation of V(D)J Recombination in a Cell-Free System by RAG1 and RAG2 Proteins
38. MicroRNAs, the DNA damage response and cancer
39. Autophosphorylation of $DNA-PK_{CS}$ Regulates Its Dynamics at DNA Double-Strand Breaks
40. Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity
41. Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer
42. Dynamic Assembly of End-Joining Complexes Requires Interaction between Ku70/80 and XRCC4
43. A novel radiosensitive SCID patient with a pronounced G 2/M sensitivity
44. A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair
45. A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture
46. A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen
47. An XRCC4 Splice Mutation Associated With Severe Short Stature, Gonadal Failure, and Early-Onset Metabolic Syndrome
48. Reaching out for the other end with p53-binding protein 1
49. Mutational Analysis of the Integrase Protein of Human Immunodeficiency Virus Type 2
50. Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.